Medplus Health Services Ltd

Q3 FY26

Medplus Health Services Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹690

Market cap₹8.3K Cr

P/E39.4

Updated23 Aug 2026

Read5 min read

The short version

MedPlus is targeting a net addition of 600 new stores in FY '26 and has already added 400 stores during the current financial year, indicating continued store expansion. No formal guidance provided for next year’s earnings, operating profits, or EPS as the company is currently finalizing its annual operating plan.

From Medplus Health Services Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

MedPlus is targeting a net addition of 600 new stores in FY '26 and has already added 400 stores during the current financial year, indicating continued store expansion.
The company aims to sustain similar store addition numbers (~400 to 600 per year) going forward.
Sustainable same-store sales growth (SSSG) is aspired to be in high-single to low-double-digit range, though no formal guidance is given yet.
Focus on increasing private label mix, particularly in non-pharma products, is expected to drive revenue and margin growth.
Growth is targeted through deeper penetration in existing states, densification of store network, and selective entry into adjacent states.
Incremental sales growth is supported by expanding the product assortment in private label non-pharma categories and improving backend efficiencies.

2 more points management made on revenue & sales performance

Profitability & Margins

No formal guidance provided for next year’s earnings, operating profits, or EPS as the company is currently finalizing its annual operating plan.
Management aspires to sustain a healthy same-store sales growth (SSSG), with ambitions internally aligned to at least maintain current levels.
Gross margins are expected to remain stable going forward.
Private label sales mix, especially in non-pharma products, is seen as a key lever for margin expansion.
Operating EBITDA margin from stores older than 12 months was 5.8%, indicating mature store profitability.
Expansion of stores is expected to continue at a similar pace as the current year, supporting revenue growth.

2 more points management made on profitability & margins

See what Medplus Health Services Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Based on the provided transcript from the MedPlus Health Services Limited Q3 FY26 earnings call, there is no explicit mention of specific current or future capex, capital investment, or strategic investment plans. However, some relevant points hinting at investments include: - Ongoing operationalization of new warehouses: 60%-70% operational, remainder expected in next two quarters, with manpower recruitment complete (Page 8). - Store network expansion: Net addition of 400 stores in current financial year with outlook to add 600 new stores in FY26; focus on densification within existing states and gradual expansion into adjacent states like Chhattisgarh and Kerala (Pages 2 and 9).

2 more points management made on capital expenditure plans

Fundraising & Capital Structure

The transcript does not mention any current or future fundraising plans through debt or equity for MedPlus Health Services Limited. Key points regarding fundraising: - No specific guidance or commentary was provided about raising funds via debt or equity during the call. - Focus is on operational growth, store expansion, and improving sales and margins. - Internal processes like expansion and incentive tweaks are highlighted, but no mention of financing actions.

2 more points management made on fundraising & capital structure

See what Medplus Health Services Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided does not explicitly mention current or expected order book or pending orders for MedPlus Health Services Limited. Key points related to operations and outlook include: - The company added a net 182 stores in the quarter, with 400 net additions in the financial year so far. - The store network expanded to 5,112 stores as of Q3 FY '26. - The company continues to target adding 600 new stores in FY '26 and expects a similar number in FY '27.

2 more points management made on order book & pipeline

Medplus Health Services Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.9K Cr, net profit ₹64 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Medplus Health Services Ltd's management said in earlier quarters

Others in Retailing this season

Indiamart Intermesh Ltd (Q3 FY26)
Collection growth accelerated to 14%, attributed to better monetization of Gold and Platinum customers and improvements in renewal rates. Key concall takeaways…
Patel Retail (Q3 FY26)
Same store sales growth (SSSG) is around 8% year-on-year. Key concall takeaways from Patel Retail Ltd's Q3 FY26 earnings call — and how it ranks against sector…
Aditya Birla Lifestyle Brands Ltd (Q3 FY26)
Network expansion will drive an additional 5%-6% growth; plans include adding around 200 stores per year with at least 3-4 years of growth headroom. Key…
Meesho Ltd (Q3 FY26)
56 crores and free cash flow to equity of Rs. Key concall takeaways from Meesho's Q3 FY26 earnings call — and how it ranks against sector peers.

Compare:vs Eternal Ltd vs Avenue Super.vs Trent Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Medplus Health Services Ltd Q3 FY26 results?

What is Medplus Health Services Ltd share price analysis?

Medplus Health Services Ltd currently shows a neutral. The stock trades at a P/E of 39.4 with a market cap of ₹8,293 Cr. Investors should review the full earnings analysis for detailed insights.

Is Medplus Health Services Ltd planning capital expenditure?

Keep Medplus Health Services Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.